Skip to content

HomeCompanies & research
CompaniesExplore European Tech
ResearchAll published research
ThemesExplore the industries
Events & EarningsDates to follow
AboutOur purpose & approach

Join free Log in

Research

Research & articles Research Notes Company updates

Search research or companiesClear filters

CompanyCountryTechnologyPublication yearOrder

Official announcements retain their original headline and source language.

12 results

Company updateOct 14, 2026

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

Valneva SECompany newsroom

Company updateOct 7, 2026

Valneva Provides Update on IXCHIQ® in the United Kingdom

Valneva SECompany newsroom

Company updateAug 14, 2026

Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Valneva SECompany newsroom

Company updateAug 13, 2026

Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates

Valneva SECompany newsroom

Company updateJul 22, 2026

Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026

Valneva SECompany newsroom

Company updateJun 25, 2026

Valneva Announces Successful Outcome of its Annual General Meeting

Valneva SECompany newsroom

Company updateJun 4, 2026

Valneva Announces Availability of Documentation for its Annual General Meeting

Valneva SECompany newsroom

Company updateMay 28, 2026

Valneva to Participate at U.S. and European Investor Conferences in June

Valneva SECompany newsroom

Company updateMay 13, 2026

Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Valneva SECompany newsroom

Company updateMay 5, 2026

Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026

Valneva SECompany newsroom

Company updateApr 30, 2026

Valneva Announces the Successful Completion of an €84 million Reserved Offering

Valneva SECompany newsroom

Company updateMar 26, 2026

Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC

Valneva SECompany newsroom

© 2026 European Tech Equities

X LinkedInSources Privacy Terms

Search companies & research

Search companies & research